Kronox Lab Sciences Limited (BOM:544187)

Market Cap	7.98B +28.7%
Revenue (ttm)	1.05B +6.5%
Net Income	286.84M +12.1%
EPS	7.81 +13.3%
Shares Out	n/a
PE Ratio	27.83
Forward PE	n/a
Dividend	0.50 (0.23%)
Ex-Dividend Date	Sep 9, 2026

Volume	1,362,320
Open	188.25
Previous Close	186.35
Day's Range	188.25 - 222.90
52-Week Range	96.00 - 222.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Kronox Lab Sciences

Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custo...

• Industry: Miscellaneous Chemical Products
• Founded: 2008
• Employees: 54
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544187

Financial Performance

In fiscal year 2026, Kronox Lab Sciences's revenue was 1.01 billion, an increase of 1.02% compared to the previous year's 1.00 billion. Earnings were 276.60 million, an increase of 8.61%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error